← Back to headlines
Chemours Targets $800M–$900M Adjusted EBITDA for 2026, Focusing on Cash Flow and Deleveraging
Chemours has set an adjusted EBITDA target of $800 million to $900 million for 2026, with a strategic focus on cash flow generation and deleveraging.
20 Feb, 17:16 — 20 Feb, 17:16
Read at source (1 outlet)
Related Stories
Amazon Is Now America’s Biggest Company. Its 17-Year Journey to Surpass Walmart. - The Wall Street Journal
3m ago
Newmont Stock Declines Despite Strong Q4 Earnings Beat Due to Lower Production Guidance
3m ago
Canada's Sienna Senior Living Reports Q4 Revenue Increase
3m ago
InterContinental Hotels Group Reports Higher Revenue Despite Challenging U.S. Market
3m ago